ABT · 10-Q · 2026Q3 · Full report

Emerging Market Pharmaceutical Growth

ABBOTT LABORATORIES · 2026-11-04 · Importance 30 · Surprise 40

Established Pharmaceutical Products sales in Key Emerging Markets increased 10.4% excluding foreign exchange in the first nine months of 2026. Growth was led by double-digit increases in several countries across Latin America and Asia Pacific. Other Emerging Markets sales rose 3.6% excluding foreign exchange over the same period.

Key facts

• Established Pharmaceutical Products sales in Key Emerging Markets increased 10.4% excluding foreign exchange in the first nine months of 2026, led by double-digit growth in several Latin America and Asia Pacific countries. source
• Other Emerging Markets Established Pharmaceutical Products sales increased 3.6% excluding foreign exchange in the first nine months of 2026. source